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ABSTRACT DNA synthesis in vitro in Brij-treated Saccha-
romyces cerevuiae requires the product of the CDC8 gene (Here-
ford, L. M. & Hartwell, L. H. (1971) Nature (London) New Biol.
234, 17M-172). Extracts ofwild-type'A364a yeast restore DNA syn-
thesis in Bri-treated cdc8, a mutant containing a thermolabile
cdc8 gene product. This constitutes a complementation assay by
which the cdc8 gene product can be monitored during purifica-
tion. A heat-stable protein responsible for this complementation
has been partially purified from both wild-type A364a cells and
from a cdc8 temperature-sensitive mutant. The complementation
activity from the mutant is thermolabile when compared to the
wild-type activity, indicating that CDC8 is the structural gene for
the protein.
The microbial eukaryote Saccharomyces cerevisia is an ideal
organism for probing the enzymatic mechanisms of DNA rep-
lication in higher cells. While displaying most of the features
of higher eukaryotic chromosome structure observed during
gene expression and DNA replication, yeast offers the advan-
tage over higher cells of rapid growth and relatively simple or-
ganization. In addition, yeast cells can exist stably in both hap-
loid and diploid states, thus facilitating the isolation of mutants
and their genetic analysis. Tremendous progress has been made
in elucidating the mechanism of DNA replication in bacteria,
by analysis of replication mutants and by biochemical charac-
terization of replication components. .-In these studies. an im-
portant advance was the development of in vitro replication
systems that allow purification of components of the complex
replication machinery by complementation analysis. Such a
combined genetic and biochemical approach for dissecting the
replication machinery should also prove profitable in yeast.
Many temperature-sensitive mutants having defects in cell
division have been isolated and characterized by Hartwell (1).
Of these, several were found to be deficient in DNA synthesis,
although only in cdc8 mutants was it, clear that the defect di-
rectly affected DNA replication (1, 2). We have examined the
existing temperature-sensitive strains for mutants specifically
defective in DNA replication, by assaying for replication in vitro
in yeast cells made permeable to nucleoside triphosphates by
the nonionic detergent Brij, as described by Hereford and Hart-
well (3). Brij-treated cells retain the morphology of intact cells
but are permeable to low molecular weight precursors ofmacro-
molecular synthesis. DNA synthesis in this system corresponds
to in vivo replication by several criteria. In particular, DNA
synthesis in the S. cere-visiae temperature-sensitive replication
mutant cdc8 is heat labile in this in vitro system (3). In addition,
as shown in this communication, synthesis is inhibited by aphi-
dicolin, an inhibitor of DNA replication in vivo. Using this
screening procedure, we have identified nine additional rep-
lication mutants (unpublished).
It was not possible to predict a priori if detergent-treated
cells would be permeable to macromolecules and thus amenable
to in vitro complementation. During the course ofthese studies,
we investigated whether Brij-treated cells of any of the DNA
replication mutants could be complemented by extracts con-
taining the wild-type gene product. cdc8 alone showed com-
plementation; DNA replication in Brij-treated cdc8 cells could
be restored by the addition ofwild type extract at the restrictive
temperature. The ability to achieve complementation with the
cdc8 defect may,. in fact, be due to the unique physical prop-
erties of the cdc8 protein described here.
In this communication we report the partial purification and
characterization of the cdc8 protein, using a complementation
assay to monitor activity. This is just the first step in ultimately
generating a molecular description of eukaryotic replication by
use of in vitro complementation to purify and to characterize
the gene products involved.
MATERIALS AND METHODS
Strains. Parental strain A364a (a adel ural gall tyrl his7
lys2) and strain 198 cdc8, derived from A364a, were provided
by John Scott (University of California. at Los Angeles).
Medium. YPD (yeast extract/peptone/dextrose) medium is
described in ref. 4.
Preparation of Receptor. Strain cdc8 was grown at 230C to
a density of 2 x 107 cells per ml in YPD medium, collected by
centrifuigation, and washed twice with H20. The cells were sus-
pended in 10 mM Tris HCI (pH 7.2)/2 M sucrose/1% Brij 58
to a final concentration of 2 x 108 cells per ml and incubated
at 300C until the cells were permeable, as monitored by mea-
suring alkaline phosphatase activity (3). The receptor prepara-
tions were prepared fresh for each assay and retained activity
at 00C for 2-3 hr.
Complementation Assay for cdc8 Activity. The standard
DNA replication reaction mixture contained 50 mM Tris HCI
(pH 8.0); 10 mM MgCl2; 1.5 mM. 2-mercaptoethanol; 50 AM
dATP, dGTP, and dCTP; 2 ,tM [a-32P]dTTP (4,000-8,000cpm/
pmol); 1 mM ATP; 10 mM phosphoenolpyruvate; 1% Brij 58;
0.05 ml of the Tris/sucrose/Brij cell suspension; and the in-
dicated amounts ofdonor fractions. After incubation for 30 min
at 37C the reaction was stopped by the addition of 3 ml of 1
M HCl/0.02 M sodium pyrophosphate, and the amount of tri-
chloroacetic acid-insoluble radioactive material was determined
(5). A unit of cdc8 activity is that amount of protein giving rise
to incorporation of 1.0 pmol of total nucleotide in 30 min.
Other Methods. Protein was measured by the method of
Lowry et al (6).
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RESULTS
DNA Synthesis in Permeabilized Yeast Cells Mimics DNA
Replication in Vivo. DNA synthesis is thermosensitive in the
thermolabile mutant cdc8. Previous studies by Hereford and
Hartwell (3) showed that yeast cells made permeable with Brij
58 could incorporate [a-3PdTTP.into acid-insoluble material
in areaction requiring Mge, ATP, and-the other three dNTPs.
The in vitro replication system apparently used the same syn-
thesizing machinery as DNA-replication-in vivo, because DNA
synthesis was defective in Brij-treated strain cdc8 at the re-
strictive temperature. As shown in Fig. 1, we have reproduced
this finding, using a modified procedure that involves more
extensive treatment with detergent. The optimal time of Brij
treatment is 40 min, a time at which maximal amounts ofalkaline
phosphatase are also measured. Whereas wild-type cells re-
spond to the detergent treatment by supporting DNA synthesis
when provided with dNTPs, no DNA synthesis over back-
ground is observed with Brij-treated cdc8 cells. The level of
synthesis in wild-type.strain A364a is 5-fold higher than that
observed in the mutant cdc8 at 370C. Residual synthesis in cd&8
probably does not represent replication -because ATP is not
required.
Synthesis is inhibited by aphidicolin. Aphidicolin, a tetra-
cyclic diterpenoid, has recently been shown to inhibit the
growth of eukaryotic cells and virus-infected cells by inhibiting
DNA replication (7, 8). Furthermore, Plevani (9) has shown that
both yeast DNA polymerase I and DNA polymerase II are in-
hibited by aphidicolin, and Sugino et al. (10) have shown that
in yeast mutants that are permeable to aphidicolin the drug in-
hibits growth.
Because inhibition ofDNA synthesis by aphidicolin provides
one additional criterion for DNA replication, we have examined
its effect on DNA synthesis in Brij-treated yeast cells. As shown
in Fig. 2, aphidicolin inhibits. DNA synthesis in the permea-
bilized cell system; at a concentration of 20 tg/ml, DNA syn-
thesis is reduced to 40% of normal. However, the addition of
increasing amounts of aphidicolin up to 100 jkg/ml does-not
eliminate this residual synthesis. This drug-resistant synthesis
may reflect the fact that dNTPs are competitive inhibitors of
aphidicolin (8) or may indicate the existence of a previously
undetected aphidicolin-resistant DNA-synthesizing system in
yeast.
Extracts ofWild-Type Yeast Restore DNA Synthesis in Per-
meabilized Cells of cdc8. Cell-free extracts prepared from a
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FIG. 1. Incorporation of [32PldTTP into DNA, at 370C plotted as a
function of time of.pretreatment for cultures of wild-type A364a and
mutant cdc8. Strains were .grown, harvested, and treated for the in-
dicated time period with Tris/sucrose/Bri DNA synthesis was then














FIG. 2. Effect of aphidicolin on DNA synthesis in permeabilized
A364a cells. DNA synthesis in Brij-treated A364a cells was measured
with the addition of indicated amounts of aphidicolin dissolved in di-
methyl sulfoxide.
wild-type A364a (donor extract) can restore synthesis to cdc8
cells made permeable by Brij treatment (receptor). As shown
in Fig 3a, extracts ofwild-type A364a stimulate DNA synthesis
in permeabilized cells of cdc8 at 37°C. In contrast, -donor ex-
tracts from strain cdc8 cannot restore the activity to the recip-
ient cdc8 preparation at 37°C (Fig. 3a). The difference in stim-
ulatory activity in extracts from wild-type and cdc8 indicates
that the donor extract is specifically providing the cdc8 gene
product.
The inability of an extract of cdc8 cells to restore DNA syn-
thesis to permeabilized cdc8 cells at 37°C is not due to non-
specific loss of activity. When assayed at. the permissive tem-
perature, cdc8 extracts can stimulate DNA synthesis in
permeabilized cdc8 cells (Fig. 3b). Thus temperature-sensitive
mutant extracts contain a thermolabile gene product. The cdc8
gene product in the. permeabilized cells is apparently more la-
bile than in the extract, perhaps because the Brij-treatment is
carried out at 30°C, whereas the extracts are prepared at 4°C.
This is an important observation, because the ability of cdc8
extracts to serve as donors in the complementation assay at 23°C
has allowed us to purify a thermolabile activity from the tem-
perature-sensitive mutant.
These observations formed the basis for the complementation
assay described in Materials and Methods. The requirements
for the complementation reaction using partially purified cdc8
protein as donor are summarized in Table 1. In addition to a
requirement for both receptor cells and a donor preparation,
there is an absolute requirement for ATP. Complementation
is inhibited by aphidicolin, just as synthesis is inhibited in wild-
type permeabilized cells. A receptor extract prepared from a
DNA replication mutant that falls in a different complemen-
tation group from cdc8, tsl2 (unpublished results), was not com-
plemented in these permeabilized cells. This result not only
shows the specificity for cdc8 in this reaction, but suggests that
this may not be a generally useful assay to isolate replication
proteins. In permeabilized diploid cells, a 2-fold increase in
overall DNA synthesis was routinely observed.
Partial Purification of the cdc8 Protein. Because the cdc8
gene product is required for DNA synthesis in permeabilized
yeast cells, wehave been able to purify the cdc8 protein by using
the complementation assay described above.. The results of a
typical purification are summarized in Table 2.
Analysis of glycerol gradient fractions by polyacrylamide gel
electrophoresis in the presence of sodium dodecyl sulfate in-
dicated that fraction V is greater than 25% pure by weight and
-Proc. Natl. Acad. Sci.'- USA 79 (1982)
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FIG. 3. Complementation of Bri-treated S. cerevisie cdc8 cells. Mutant cdc8 was grown at 23TC to a density of 2 x 107 cells perml and permeable
cells were prepared (receptor). The standard complementation reaction mixture contained receptor cells and the indicated amounts of either wild-
type (e) or cdc8 (A) extract. Incubation was for 30 min at either 37TC (a) or 23TC (b).
substantially purer on a molar basis. The glycerol gradient data
allow a preliminary estimate of the sedimentation constant of
the cdc8 protein that is consistent with a molecular weight (as-
suming it is a globular protein) of 10,000-20,000, which is also
in reasonable agreement with the gel electrophoresis results.
Properties of the Purified cdc8 Protein. Purified cdc8 pro-
tein can complement permeabilized cdc8 cells. Although the
cdc8 protein could be purified from extracts by virtue of its
ability to restore DNA synthesis to permeabilized cdc8 cells,
the purified protein is much more efficient than crude prepa-
rations in stimulating synthesis. As shown in Fig. 4, 25 ,ug of
cdc8 protein leads to a 10-fold stimulation ofactivity in the com-
plementation assay at 37C. The stimulatory activity is linear
for amounts of cdc8 protein ranging between 2.0 and 10 jug in
the assay. Saturating amounts of cdc8 protein give a 30-fold
stimulation of activity (data not shown). Results presented in
Fig. 3, however, showed that only a 5-fold stimulation could be
achieved with saturating amounts of extract. This is easily ex-
plicable if an inhibitor is removed during purification.
Complementation activity of the cdc8 protein purifedfrom
the temperature-sensitive mutant cdc8 is thermolabile. The cdc8
protein was also purified from extracts of S. cerevisiae cdc8
through the phosphocellulose step as described above. The pu-
rification was monitored by complementation assay at 230C, a
temperature at which the cdc8 protein from this strain com-
plements the mutant extract effectively (see Fig. 3b). When
fraction IV was assayed at 37C, however, complementing ac-
tivity was abolished (Table 3). This is in sharp contrast to the
wild-type protein, which has the same activity at 230C and 370C.
Because the preparation from strain cdc8 is thermolabile, the
Table 1. Requirements of the complementation assay
DNA synthesis, pmol dTTP





Add aphidicolin (20 mg/ml) 0.23
Omit cdc8 receptor <0.1
Omit cdc8 gene product <0.1
Omit cdc8 receptor, add ts12 receptor <0.1
The assay conditions were as described in Materials and Methods,
with the omissions and additions noted. Each reaction mixture (except
the second-to-last) contained 10 jg of partially purified cdc8 protein.
complementation activity is the product of the structural gene
for cdc8.
Complemnentation by partially purified cdc8 protein is aphi-
dicolin sensitive. After addition of aphidicolin, synthesis in the
complementation assay using wild-type cdc8 protein was re-
duced to 40%, a value similar to that obtained with permea-
bilized A364a (compare Fig. 2). This argues for, though does
not alone establish that, replicative synthesis occurs in this
assay.
Heat stability of the cdc8 activity. As shown in Table 4, the

















FRACTION I V (fig)
FIG. 4. Complementation by purified cdc8 protein and inhibition
by proteinase K. Receptor cdc8 cells were prepared, indicated amounts
of cdc8 protein (fraction IV) were added, and incubation was carried
out as in the legend to Fig. 3. The lower curve (o) represents reaction
mixtures that contained cdc8 protein that had been treated with pro-
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Fraction Step mg units/mg %
I Crude extract 166 4.7 100
II Streptomyocin and 73.7 14.2 134
(NH4)2S04
III DEAE-cellulose 22.7 52.0 150
IV Phosphocellulose 1.36 924.4 160
V* Glycerol gradient 0.04 2900 13.5
Growth, storage of cells and preparation of donor extracts. Strains
A364a and cdc8 were grown at 230C to late logarithmic phase in YPD
medium, collected by centrifugation, washed twice with H20, and
stored in liquid nitrogen. All subsequent procedures were carried out
at 0-40C. For preparation of extracts, cell paste was thawed, diluted
with a solution of Zymolyase 60,000 (0.5 mg/ml in H20), and adjusted
to OD590 = 400. The cells were incubated at 300C for 30 min, at which
time spheroplast formation was complete. The spheroplasts were
mixed on a Vortex mixer with glass beads and then disrupted in a
chilled homogenizer. The supernatant was then collected by centrif-
ugation at 10,000 x g for 40 min (fraction I). Streptomyocin and am-
monium sulfate fractionation. A solution of 30% streptomyocin sulfate
was added to extracts to a final concentration of 5%. After stirring for
30 min, the suspension was centrifuged at 20,000 x g for 20 min. Solid
(NH4)2SO4 (0.47 g/ml) was added to the supernatant fluid and the
protein precipitate was collectedby centrifugation. The precipitate was
dissolved in buffer A [20 mM Tris HCl (pH 7.6)/1 mM EDTA/1 mM
2-mercaptoethanol/20% (wt/vol) glycerol] and dialyzed against the
same buffer (fraction II). DEAE-cellulose column chromatography.
Fraction 11 (0.8 ml) was diluted with 0.8 ml of buffer A and applied to
a 5-ml DE52 (Whatman) DEAE-cellulose column equilibrated with
buffer A. The column was washed and then eluted with a 50-ml linear
gradient of NaCl (0.1-0.6 M) in buffer A. Fractions containing the com-
plementation activity were pooled and precipitated by the addition of
ammonium sulfate (0.47 g/ml). The precipitate was collected by cen-
trifugation, resuspended in 0.5 ml of bufferB [20mMTris HCl (pH 7.0)/
1 mM EDTA/1 mM 2-mercaptoethanol/20% (wt/vol) glycerol] and
then dialyzed (fraction III). Phosphocellulose P-il column chromatog-
raphy. Fraction III was diluted with 0.5 ml of buffer B and applied to
a 4-ml phosphocellulose P-11 (Whatman) column equilibrated with
buffer B. The column was washed and protein was eluted with a 50-ml
linear gradient of NaCl (0.1-0.6 M) in buffer B. Fractions containing
complementation activity, which eluted at 0.13 M NaCl, were pooled,
concentrated by (NH4)2SO4 precipitation, redissolved in buffer C (the
same as buffer A except that 0.1 mM dithiothreitol is substituted for
2-mercaptoethanol), and dialyzed against the same buffer (fraction IV).
Glycerol gradient sedimentation. Fraction IV was dialyzed against buf-
fer C containing 5% (wt/vol) glycerol and layered on a 4.6-ml linear
gradient of 10-30% (wt/vol) glycerol containing 0.02 M Tris HCl (pH
7.5), 10mM 2-mercaptoethanol, and 10mM NaCl. Centrifugation was
at 45,000 rpm at 200 for 28 hr in a Spinco SW 50.1 rotor. The following
proteins were used as standards: alcohol dehydrogenase, bovine serum
albumin, hemoglobin, and cytochrome c.
* This step was performed on only a portion of fraction IV and the val-
ues in the table were obtained by multiplying by the appropriate
factor.
37°C was highly stable, being resistant to incubation at 650C.
After 10 min at 65°C, 80% of the activity remained.
cdc8 activity resides in a protein. The lack of activity in frac-
tions from cdc8 extracts at the restrictive temperature, shown
in Table 3, indicates that the activity resides in a protein or
RNA. The activity is resistant to RNase A, however, ruling out
that it is an RNA molecule. The activity is also resistant to pa-
pain, even at 65°C, a property possibly related to its resistance
to heat denaturation (Table 4). However proteinase K, a pro-
tease generally considered to be more active toward proteins
in native configurations than other proteases, does inactivate
cdc8 activity (Table 4, Fig. 4). Controls showed that proteinase
K had no effect on synthesis in permeabilized wild-type A364a




Protein Assay Assay Activity ratio,
source at 230C at 370C 370C/230C
Wild-type 1.2 1.2 1.0
cdc8 0.80 0.11 0.13
Fraction IV (10 pug) was assayed at 230C and 3700 in the comple-
mentation assay. There was no measurable activity at 3700 when pro-
tein from strain cdc8 was added.
cells under the conditions in which it inhibited cdc8 comple-
mentation.
DISCUSSION
The cdc8 protein is essential for DNA replication in vivo and
is required for cell division. When strain cdc8 grown at the per-
missive temperature, 230C, is shifted to the restrictive tem-
perature, 360C, cells accumulate with a nucleus that remains
undivided but is located at the isthmus between parent cell and
bud. The first wave of DNA synthesis after shift up does not
occur (1). The product of the cdc8 gene is apparently required
throughout the period ofDNA synthesis, because when a syn-
chronized culture ofcells defective in the gene is shifted to 36TC
within the S period, nuclear DNA replication ceases immedi-
ately (2). Mitochondrial DNA replication also ceases at the non-
permissive temperature in cdc8 mutants (11). Electron micro-
scopic examination of chromosomes in cdc8 cells placed at the
nonpermissive temperature for approximately two generation
times shows a high proportion of molecules that contain repli-
cation "bubbles." The "bubbles" contain two double-stranded
branches with an average length of 3 Am (12).
The formation of replication intermediates at the nonper-
missive temperature suggests that the cdc8 mutant can initiate
DNA synthesis at the nonpermissive temperature, while the
small size of these "bubbles" may indicate a reduced rate of
chain propagation. Thus, the in vivo results suggest a role of the
cdc8 protein at the replication fork.
Another interesting property of cdc8 mutants is that DNA
extracted at the nonpermissive temperature also contains clus-
ters of small denatured regions, approximately 300 base pairs
in length (13). Denatured regions appear on both newly rep-
licated and unreplicated DNA, and disappear upon centrifu-
gation in CsCl, suggesting that the DNA in this region may be




650C, 10 min 80
Papain at 20 mg/ml, 370C, 30 min 94
Papain at 20 pg/ml, 650C, 30 min 76
Proteinase K at 100 gg/ml, 370C, 30 min 51
Proteinase K at 100 yg/ml, 650C, 30 min <1
RNase A at 50 ,ug/ml, 370C, 30 min 97
Purified cdc8 (fraction IV) was subjected to various treatments.
Treatment with RNase or papain was performed in 0.1M Tris HCl (pH
7.0). The partially purified protein activity was then determined by
assay as described in the legend to Fig. 1, using 10 jig of fraction IV
and with the indicated additions. All values cited are relative to con-
trols carried through identical procedures except for the omission of
the indicated agents. The control for heat treatment was maintained
at 0OC.
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noncovalently bound to protein (16). Such single-stranded re-
gions could be envisioned as intermediates in recombination or
replication. Biochemical studies to date indicate that cdc8
strains are not deficient in precursor synthesis (3). Further-
more, cdc8 does not code for one ofthe yeast DNA polymerases
(14, 15).
Our findings agree with those of Hereford and Hartwell (3)
that incorporation ofdNTPs into permeabilized yeast cells cor-
responds to DNA replication in vivo. One of the strongest ar-
guments for this is the finding that Brij-treated S. cerevisiae
cdc8 is incapable of carrying out DNA synthesis at the nonper-
missive temperature. Also, we have shown that the synthesis
is sensitive to aphidicolin, an inhibitor of yeast replication (9,
10). One point that is not resolved is whether nuclear or mi-
tochondrial replication is being observed, because DNA syn-
thesis occurs on the endogenous DNA template. Banks (16) sug-
gests that all synthesis is mitochondrial, whereas our results
indicate that some p0 strains, that is, strains without mitochon-
drial DNA, are just as active in vitro as p+ strains (unpublished).
For the current work, resolution of this question is not impor-
tant, because CDC8 function is required for both nuclear and
mitochondrial replication.
We have extended the earlier studies of Hereford and Hart-
well (3) by showing that extracts ofwild-type yeast can stimulate
DNA synthesis in the permeabilized mutant cdc8. This was sur-
prising because the Brij-treated cells retain the morphology of
intact cells. The Brij-treated yeast cells are analogous to tol-
uene-treated Escherichia coli, which also carry out DNA rep-
lication on endogenous templates in a reaction dependent on
Mg2e and ATP (17). When toluene-treated E. coli are treated
with the detergent Triton X-100, DNA polymerase I and lactate
dehydrogenase are free to diffuse from the cells, and repair syn-
thesis in the cells is inhibited by antibody to DNA polymerase
I (18), indicating that the cells are permeable to macromole-
cules. We therefore tested whether this yeast system was
permeable to proteins by looking for complementation in our
mutants and found that cdc8 showed complementation. We
were thus able to use permeabilized yeast cells as receptor ex-
tracts in an in vitro complementation assay to purify the cdc8
protein.
Using conventional methods ofpurification, we have purified
the cdc8 protein 600-fold. We have shown that CDC8 is the
structural gene for the protein by purifying a thermolabile ac-
tivity from the temperature-sensitive cdc8 mutant. Perhaps the
most striking property of this protein is its resistance to heating
at 65°C and to high levels ofpapain even at 65°C. Even for pro-
teinase K, a partially denatured protein is required for proteo-
lytic inactivation. Such stability properties are usually attrib-
uted to proteins of small size.
What is the function of the cdc8 protein? Results presented
here indicate that it participates in DNA replication. In addi-
tion, we have recently developed a fully soluble system that
carries out replication in vitro of exogenous covalently closed
circular yeast DNAs that, by many criteria, mimics in vivo rep-
lication (unpublished results). Synthesis in vitro is temperature
Proc. Natl Acad. Sci. USA 79 (1982) 4247
sensitive in extracts prepared from cdc8 mutants, and the defect
can be complemented by the partially purified cdc8 protein.
Several small heat-stable proteins have been described that
participate in replication in prokaryotes. One ofthem is the E.
coli helix-destabilizing protein (Mr 18,500) (19, 20). Single-
strand DNA-binding proteins are known to participate in events
at the replication fork, and a mutation affecting such a protein
could give rise to the cdc8 phenotype. In fact, mutants ofE. coli
that contain a temperature-sensitive helix-destabilizing protein
do not grow at high temperature (20). Other small heat-stable
proteins have been found in various replication systems [e.g.,
the Mr 11,000 E. coli thioredoxin, a subunit of phage 17 DNA
polymerase (21)]. There is also a class of small heat-stable pro-
teins involved in eukaryotic DNA metabolism, namely the his-
tones. Clearly the role ofthe cdc8 protein will be resolved only
when homogeneous preparations of the protein are available.
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